At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Placebo +2 moredrug
Likely dose
Pregabalin 75 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Methodology Study To Assess The Feasibility Of Using Functional Magnetic Resonance Imaging (fRMI) To Quantify The Effects Of Analgesic Drugs In Post-Traumatic Neuropathic Pain Subjects
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·interventional·Posted Feb 7, 2008·Updated Jan 22, 2021
In Brief
A clinical study evaluating Placebo, Pregabalin, and 1 other intervention for Pain. Completed, enrolled 18 participants across 2 sites.
Detailed Summary
This study is a methodology study designed to discover whether a brain imaging technology is a better way of compare the relative sensitivities of fMRI and subjective psychometric assessments of pain to multiple doses of pregabalin and tramadol SR in a cross-over clinical study design.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited Kingdom
CollaboratorsUniversity of Oxford
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2008
Enrollment StartSep 2008
Primary CompletionJul 2010
TodayJul 2026
First PostedFeb 7, 2008
Enrollment StartSep 1, 2008
Primary CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.4 years ago
Interventions
Placebodrug
BID
Pregabalindrug
Dose 75 mg titrated to 150 mg, bid
Tramadol SRdrug
Dose 50mg titrated to 200 mg, bid